The use of iron chelators in biocidal compositions: Evaluation of patent, WO2014059417A1

Expert Opinion on Therapeutic Patents

Volumn 25, Issue 3, 2015, Pages 367-372

  Sahni, Sumit ^a   Krishan, Sukriti ^a   Palanimuthu, Duraippandi ^a   Richardson, Des R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anti microbial agents; Biocidal activity; Iron chelators

Indexed keywords

BIOCIDE; COSMETIC; DOMESTIC CHEMICAL; IRON CHELATING AGENT; PAINT; PRESERVATIVE; UNCLASSIFIED DRUG; WO 2014059417A1; WOUND HEALING PROMOTING AGENT; ANTIINFECTIVE AGENT; DISINFECTANT AGENT;

ACNE; ANTIBACTERIAL ACTIVITY; CHEMICAL COMPOSITION; DRUG FORMULATION; EVALUATION STUDY; HUMAN; PATENT; REVIEW; ACNE VULGARIS; DRUG EFFECTS; DRUG POTENTIATION; WOUND HEALING;

ACNE VULGARIS; ANTI-INFECTIVE AGENTS; DISINFECTANTS; DRUG SYNERGISM; HUMANS; IRON CHELATING AGENTS; PATENTS AS TOPIC; WOUND HEALING;

EID: 84922932546     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2014.989215     Document Type: Review

References (17)

1. Fairbanks VF, Beutler E. Iron metabolism. Williams Hematology 1995;6:295-304
2. Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007;17:93-100
3. Marx J. Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002;15:411-26
4. Ballouche M, Cornelis P, Baysse C. Iron metabolism: a promising target for antibacterial strategies. Recent Pat Antiinfect Drug Discov 2009;4:190-205
5. Bergeron R, Elliott G, Kline S, et al. Bacteriostatic and fungostatic action of catecholamide iron chelators. Antimicrob Agents Chemother 1983;24:725-30
6. Bertrand S, Helesbeux J-J, Larcher G, et al. Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities. Mini Rev Med Chem 2013;13:1311-26
7. Jones RL, Grady RW. Siderophores as antimicrobial agents. Eur J Clin Microbiol Infect Dis 1983;2:411-13
8. Van Asbeck B, Marcelis J, Marx J, et al. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid. Eur J Clin Microbiol 1983;2:426-31
9. Ellis S, Kalinowski DS, Leotta L, et al. Potent Antimycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analog 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: a Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide. Mol Pharmacol 2014;85:269-78
10. Debebe Z, Ammosova T, Breuer D, et al. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets-iron, cyclin-dependent kinase (CDK) 2, and CDK9. Mol Pharmacol 2011;79:185-96
11. Warner RR, Schwartz JR, Boissy Y, et al. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001;45:897-903
12. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003;4:473-92
13. Alvarez OM, Mertz PM, Eaglstein WH. Benzoyl peroxide and epidermal wound healing. Arch Dermatol 1983;119:222-5
14. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379:361-72
15. Board of Regents. The University of Texas System. M-EDTA pharmaceutical preparations and uses thereof. US5362754A;1994
16. Wen J, Zhao K, Gu T, et al. Chelators enhanced biocide inhibition of planktonic sulfate-reducing bacterial growth. World J Microbiol Biotechnol 2010;26:1053-7
17. Wen J, Zhao K, Gu T, et al. A green biocide enhancer for the treatment of sulfate-reducing bacteria (SRB) biofilms on carbon steel surfaces using glutaraldehyde. Int Biodeterior Biodegrad 2009;63:1102-6